PB-22
PB-22 is a synthetic cannabinoid that is used as an active ingredient in synthetic cannabis products. It was first identified in 2013 in samples of synthetic cannabis products sold in Japan. PB-22 is an analog of JWH-018 which has a quinolinyl group, instead of a naphthoyl group. The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications.
Chemistry[edit | edit source]
PB-22 is a derivative of JWH-018, but instead of a naphthoyl group, it has a quinolinyl group. The structure of PB-22 is related to that of other synthetic cannabinoids, including AM-2201, AM-694, AM-1241, and AM-2233. It is a white, crystalline powder that is soluble in organic solvents.
Pharmacology[edit | edit source]
The pharmacological properties of PB-22 are not well-studied. However, it is known to act as a potent agonist for the CB1 receptor, with a Ki of 5.2 nM. This makes it roughly equivalent in potency to JWH-018, although the effects in humans are not known.
Legal status[edit | edit source]
PB-22 is a Schedule I controlled substance in the United States, and is also controlled in many other countries. It is illegal to manufacture, distribute, or possess PB-22 in these jurisdictions.
See also[edit | edit source]
PB-22 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD